Strengthening lung health through science
Respiratory diseases affect a significant portion of the population. Conditions like asthma, allergic rhinitis, and infections require integrated therapeutic approaches.
Gut microbiota influences lung immunity and inflammation through immune signaling.
Dysbiosis is linked to asthma, COPD, and respiratory infections.
Probiotics and microbiome modulation show promise in respiratory care.
Therapies targeting allergic and chronic respiratory diseases
Microbiome-based immune modulation strategies
Discover how our innovative solutions can transform patient outcomes